17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyprogesterone caproate.
Abiraterone
The metabolism of Glyburide can be decreased when combined with Abiraterone.
Acarbose
Acarbose may increase the hypoglycemic activities of Glyburide.
Advertisement
Acebutolol
Acebutolol may increase the hypoglycemic activities of Glyburide.
Acenocoumarol
Glyburide may increase the anticoagulant activities of Acenocoumarol.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Glyburide.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.
Acetyl Sulfisoxazole
The metabolism of Glyburide can be decreased when combined with Acetyl sulfisoxazole.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Glyburide.
Advertisement
Albiglutide
Albiglutide may increase the hypoglycemic activities of Glyburide.
Alogliptin
Alogliptin may increase the hypoglycemic activities of Glyburide.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Glyburide.
Alprenolol
Alprenolol may increase the hypoglycemic activities of Glyburide.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Glyburide.
Amiodarone
The metabolism of Glyburide can be decreased when combined with Amiodarone.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Glyburide.
Anhydrous Tacrolimus
The therapeutic efficacy of Glyburide can be decreased when used in combination with Tacrolimus.
Apalutamide
The serum concentration of Glyburide can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Glyburide can be increased when it is combined with Aprepitant.
Aripiprazole
The therapeutic efficacy of Glyburide can be decreased when used in combination with Aripiprazole.
Armodafinil
The metabolism of Glyburide can be decreased when combined with Armodafinil.
Arsenic Trioxide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Glyburide.
Atazanavir
The metabolism of Glyburide can be decreased when combined with Atazanavir.
Atenolol
Atenolol may increase the hypoglycemic activities of Glyburide.
Atomoxetine
The metabolism of Glyburide can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Glyburide is combined with Atorvastatin.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Glyburide.
Bendroflumethiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Bendroflumethiazide.
Benzthiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Benzthiazide.
Betamethasone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Betamethasone.
Betaxolol
Betaxolol may increase the hypoglycemic activities of Glyburide.
Bezafibrate
Bezafibrate may increase the hypoglycemic activities of Glyburide.
Bisoprolol
Bisoprolol may increase the hypoglycemic activities of Glyburide.
Boceprevir
The metabolism of Glyburide can be decreased when combined with Boceprevir.
Bopindolol
Bopindolol may increase the hypoglycemic activities of Glyburide.
Bortezomib
The metabolism of Glyburide can be decreased when combined with Bortezomib.
Bosentan
Glyburide may increase the hepatotoxic activities of Bosentan.
Bosentan Anhydrous
Glyburide may increase the hepatotoxic activities of Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Glyburide.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Glyburide.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Glyburide.
Brexpiprazole
The therapeutic efficacy of Glyburide can be decreased when used in combination with Brexpiprazole.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Glyburide.
Bumetanide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Bumetanide.
Bupranolol
Bupranolol may increase the hypoglycemic activities of Glyburide.
Buserelin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Buserelin.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Glyburide.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Glyburide.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Glyburide.
Capecitabine
The metabolism of Glyburide can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Glyburide can be increased when combined with Carbamazepine.
Carbocysteine
The risk or severity of adverse effects can be increased when Glyburide is combined with Carbocisteine.
Carteolol
Carteolol may increase the hypoglycemic activities of Glyburide.
Carvedilol
Carvedilol may increase the hypoglycemic activities of Glyburide.
Celiprolol
Celiprolol may increase the hypoglycemic activities of Glyburide.
Ceritinib
The serum concentration of Glyburide can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Glyburide.
Chloramphenicol
The metabolism of Glyburide can be decreased when combined with Chloramphenicol.
Chlorothiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Chlorpropamide may increase the hypoglycemic activities of Glyburide.
Chlorthalidone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorthalidone.
Cholecalciferol
The metabolism of Glyburide can be decreased when combined with Cholecalciferol.
Cholic Acid
Glyburide may decrease the excretion rate of Cholic Acid which could result in a higher serum level.
Cimetidine
The serum concentration of Glyburide can be increased when it is combined with Cimetidine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Glyburide.
Ciprofibrate
Ciprofibrate may increase the hypoglycemic activities of Glyburide.
Ciprofloxacin
Ciprofloxacin may increase the hypoglycemic activities of Glyburide.
Citalopram
The metabolism of Glyburide can be decreased when combined with Citalopram.
Clarithromycin
The serum concentration of Glyburide can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Glyburide can be decreased when combined with Clemastine.
Clofibrate
Clofibrate may increase the hypoglycemic activities of Glyburide.
Clotrimazole
The metabolism of Glyburide can be decreased when combined with Clotrimazole.
Clozapine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Clozapine.
Cobicistat
The metabolism of Glyburide can be decreased when combined with Cobicistat.
coenzyme Q10
The therapeutic efficacy of Glyburide can be increased when used in combination with Ubidecarenone.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Glyburide.
Colesevelam
The serum concentration of Glyburide can be decreased when it is combined with Colesevelam.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Glyburide.
Corticotropin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Cortisone acetate.
Crisaborole
The metabolism of Glyburide can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Glyburide can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Glyburide can be decreased when combined with Curcumin.
Cyclopenthiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclopenthiazide.
Cyclosporine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.
Cyproterone Acetate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Glyburide.
Dabrafenib
The serum concentration of Glyburide can be decreased when it is combined with Dabrafenib.
Danazol
The therapeutic efficacy of Glyburide can be decreased when used in combination with Danazol.
Dapagliflozin
Dapagliflozin may increase the hypoglycemic activities of Glyburide.
Darunavir
The metabolism of Glyburide can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Glyburide can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Glyburide can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Glyburide can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Glyburide can be decreased when combined with Delavirdine.
Desipramine
Desipramine may increase the hypoglycemic activities of Glyburide.
Desogestrel
The therapeutic efficacy of Glyburide can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Glyburide.
Dexamethasone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Diazoxide.
Dicumarol
Glyburide may increase the anticoagulant activities of Dicoumarol.
Dienogest
The therapeutic efficacy of Glyburide can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Glyburide.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Glyburide.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Glyburide.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Glyburide.
Diltiazem
The metabolism of Glyburide can be decreased when combined with Diltiazem.
Disopyramide
Disopyramide may increase the hypoglycemic activities of Glyburide.
Dothiepin
The metabolism of Glyburide can be decreased when combined with Dosulepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Glyburide.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Glyburide.
Doxycycline
The metabolism of Glyburide can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Glyburide can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Glyburide can be decreased when combined with Dronedarone.
Drospirenone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Drospirenone.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Glyburide.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Glyburide.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Glyburide.
Efavirenz
The metabolism of Glyburide can be decreased when combined with Efavirenz.
Eltrombopag
The serum concentration of Glyburide can be increased when it is combined with Eltrombopag.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Glyburide.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Glyburide.
Enzalutamide
The serum concentration of Glyburide can be decreased when it is combined with Enzalutamide.
Epinephrine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Epinephrine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Glyburide.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Glyburide.
Ertugliflozin
Ertugliflozin may increase the hypoglycemic activities of Glyburide.
Erythromycin
The metabolism of Glyburide can be decreased when combined with Erythromycin.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Glyburide.
Eslicarbazepine Acetate
The metabolism of Glyburide can be decreased when combined with Eslicarbazepine acetate.
Esmolol
Esmolol may increase the hypoglycemic activities of Glyburide.
Esomeprazole
The metabolism of Glyburide can be decreased when combined with Esomeprazole.
Estradiol
The therapeutic efficacy of Glyburide can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Glyburide can be decreased when used in combination with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Glyburide is combined with Ethanol.
Ethinyl Estradiol
The therapeutic efficacy of Glyburide can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Ethynodiol diacetate.
Etofibrate
Etofibrate may increase the hypoglycemic activities of Glyburide.
Etonogestrel
The therapeutic efficacy of Glyburide can be decreased when used in combination with Etonogestrel.
Etravirine
The metabolism of Glyburide can be decreased when combined with Etravirine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Glyburide.
Exenatide
Exenatide may increase the hypoglycemic activities of Glyburide.
Fenofibrate
Fenofibrate may increase the hypoglycemic activities of Glyburide.
Fenofibric Acid
Fenofibric acid may increase the hypoglycemic activities of Glyburide.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Glyburide.
Floxuridine
The metabolism of Glyburide can be decreased when combined with Floxuridine.
Fluconazole
The serum concentration of Glyburide can be increased when it is combined with Fluconazole.
Fludrocortisone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Fludrocortisone.
Fluindione
Glyburide may increase the anticoagulant activities of Fluindione.
Flumequine
Flumequine may increase the hypoglycemic activities of Glyburide.
Fluorouracil
The metabolism of Glyburide can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Glyburide can be decreased when combined with Fluoxetine.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Glyburide.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Glyburide.
Fluvoxamine
The metabolism of Glyburide can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Glyburide can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Glyburide can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Glyburide can be increased when combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Glyburide.
Furosemide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Furosemide.
Fusidate
The serum concentration of Glyburide can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Glyburide can be increased when it is combined with Fusidic Acid.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Glyburide.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Glyburide.
Gemfibrozil
The metabolism of Glyburide can be decreased when combined with Gemfibrozil.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Glyburide.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Glyburide.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Glyburide.
Gliclazide
Glyburide may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Glimepiride may increase the hypoglycemic activities of Glyburide.
Glipizide
Glyburide may increase the hypoglycemic activities of Glipizide.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Glyburide.
Goserelin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Glyburide.
Histrelin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyprogesterone caproate.
Hypoxis hemerocallidea root extract
The serum concentration of Glyburide can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Glyburide.
Idelalisib
The metabolism of Glyburide can be decreased when combined with Idelalisib.
Iloperidone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Iloperidone.
Imatinib
The metabolism of Glyburide can be decreased when combined with Imatinib.
Indapamide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Indapamide.
Indinavir
The metabolism of Glyburide can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Glyburide can be decreased when combined with Indinavir.
Insulin Detemir
Glyburide may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Glyburide.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Glyburide.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Glyburide.
Insulin, Aspart Protamine, Human
Glyburide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Glyburide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Glyburide may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Glyburide.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Glyburide.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Glyburide.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Glyburide.
Irbesartan
The metabolism of Glyburide can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Glyburide can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Glyburide can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Glyburide.
Isoniazid
The metabolism of Glyburide can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Glyburide can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Glyburide can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Glyburide can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Glyburide can be decreased when combined with Ketoconazole.
Labetalol
Labetalol may increase the hypoglycemic activities of Glyburide.
Lanreotide
Glyburide may increase the hypoglycemic activities of Lanreotide.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Glyburide.
Leflunomide
The metabolism of Glyburide can be decreased when combined with Leflunomide.
Leuprolide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Leuprolide.
Levobetaxolol
Levobetaxolol may increase the hypoglycemic activities of Glyburide.
Levobunolol
Levobunolol may increase the hypoglycemic activities of Glyburide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Glyburide.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Glyburide.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Glyburide.
Levonorgestrel
The therapeutic efficacy of Glyburide can be decreased when used in combination with Levonorgestrel.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Glyburide.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Glyburide.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Glyburide.
Lixisenatide
Lixisenatide may increase the hypoglycemic activities of Glyburide.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Glyburide.
Lopinavir
The metabolism of Glyburide can be decreased when combined with Lopinavir.
Losartan
The metabolism of Glyburide can be decreased when combined with Losartan.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Glyburide.
Luliconazole
The serum concentration of Glyburide can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Glyburide can be decreased when it is combined with Lumacaftor.
Lurasidone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Lurasidone.
Manidipine
The metabolism of Glyburide can be decreased when combined with Manidipine.
Mecasermin
Glyburide may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Glyburide may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Glyburide can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Megestrol acetate.
Mepindolol
Mepindolol may increase the hypoglycemic activities of Glyburide.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Glyburide.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Glyburide.
Mestranol
The therapeutic efficacy of Glyburide can be decreased when used in combination with Mestranol.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Glyburide.
Metformin
Metformin may increase the hypoglycemic activities of Glyburide.
Methotrimeprazine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Glyburide.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Glyburide.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Glyburide.
Methylprednisolone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Glyburide.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Glyburide.
Metipranolol
Metipranolol may increase the hypoglycemic activities of Glyburide.
Metolazone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Metolazone.
Metoprolol
Metoprolol may increase the hypoglycemic activities of Glyburide.
Metreleptin
Metreleptin may increase the hypoglycemic activities of Glyburide.
Miconazole
Miconazole may increase the hypoglycemic activities of Glyburide.
Midostaurin
The metabolism of Glyburide can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Glyburide can be increased when it is combined with Mifepristone.
Miglitol
Miglitol may increase the hypoglycemic activities of Glyburide.
Miglustat
Miglustat may increase the hypoglycemic activities of Glyburide.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Glyburide.
Minaprine
Minaprine may increase the hypoglycemic activities of Glyburide.
Mitotane
The serum concentration of Glyburide can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Glyburide can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Glyburide can be decreased when combined with Modafinil.
Moxifloxacin
Moxifloxacin may increase the hypoglycemic activities of Glyburide.
Nabilone
The metabolism of Glyburide can be decreased when combined with Nabilone.
Nadolol
Nadolol may increase the hypoglycemic activities of Glyburide.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Glyburide.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Glyburide.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Glyburide.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Glyburide.
Nateglinide
Nateglinide may increase the hypoglycemic activities of Glyburide.
Nebivolol
Nebivolol may increase the hypoglycemic activities of Glyburide.
Nefazodone
The metabolism of Glyburide can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Glyburide can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Glyburide can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Glyburide can be increased when combined with Nevirapine.
Niacin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Glyburide.
Nicardipine
The metabolism of Glyburide can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Glyburide.
Nilotinib
The metabolism of Glyburide can be decreased when combined with Nilotinib.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Glyburide.
Norethindrone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Glyburide.
Norgestimate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Norgestimate.
Octreotide
Octreotide may increase the hypoglycemic activities of Glyburide.
Ofloxacin
Ofloxacin may increase the hypoglycemic activities of Glyburide.
Olanzapine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Olanzapine.
Olaparib
The metabolism of Glyburide can be decreased when combined with Olaparib.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Glyburide.
Omeprazole
The metabolism of Glyburide can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Glyburide can be increased when it is combined with Osimertinib.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Glyburide.
Oxprenolol
Oxprenolol may increase the hypoglycemic activities of Glyburide.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Glyburide.
Palbociclib
The serum concentration of Glyburide can be increased when it is combined with Palbociclib.
Paliperidone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Paliperidone.
Pantoprazole
The metabolism of Glyburide can be decreased when combined with Pantoprazole.
Pargyline
Pargyline may increase the hypoglycemic activities of Glyburide.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Glyburide.
Pasireotide
Glyburide may increase the hypoglycemic activities of Pasireotide.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Glyburide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Glyburide.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Glyburide.
Penbutolol
Penbutolol may increase the hypoglycemic activities of Glyburide.
Pentamidine
Pentamidine may increase the hypoglycemic activities of Glyburide.
Pentobarbital
The metabolism of Glyburide can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Glyburide.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Glyburide.
Phenformin
Phenformin may increase the hypoglycemic activities of Glyburide.
Phenindione
Glyburide may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Glyburide can be increased when combined with Phenobarbital.
Phenprocoumon
Glyburide may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Glyburide can be increased when combined with Phenytoin.
Pindolol
Pindolol may increase the hypoglycemic activities of Glyburide.
Pioglitazone
Pioglitazone may increase the hypoglycemic activities of Glyburide.
Piperazine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Pipotiazine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Glyburide.
Polythiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Polythiazide.
Posaconazole
The metabolism of Glyburide can be decreased when combined with Posaconazole.
Practolol
Practolol may increase the hypoglycemic activities of Glyburide.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Glyburide.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Glyburide.
Prednisolone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Glyburide.
Primidone
The metabolism of Glyburide can be increased when combined with Primidone.
Probenecid
The protein binding of Glyburide can be decreased when combined with Probenecid.
Procaine
Procaine may increase the hypoglycemic activities of Glyburide.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Glyburide.
Progesterone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Progesterone.
Propafenone
Propafenone may increase the hypoglycemic activities of Glyburide.
Propranolol
Propranolol may increase the hypoglycemic activities of Glyburide.
Pyrimethamine
The metabolism of Glyburide can be decreased when combined with Pyrimethamine.
Quetiapine
The therapeutic efficacy of Glyburide can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Glyburide can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Quinethazone.
Quinine
The metabolism of Glyburide can be decreased when combined with Quinine.
Ranitidine
The serum concentration of Glyburide can be increased when it is combined with Ranitidine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Glyburide.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Glyburide.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Glyburide.
Repaglinide
Repaglinide may increase the hypoglycemic activities of Glyburide.
Rifabutin
The metabolism of Glyburide can be increased when combined with Rifabutin.
Rifampin
The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.
Rifapentine
The metabolism of Glyburide can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Glyburide.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Glyburide.
Risperidone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Glyburide can be decreased when used in combination with Ritonavir.
Rolapitant
The serum concentration of Glyburide can be increased when it is combined with Rolapitant.
Rosiglitazone
Rosiglitazone may increase the hypoglycemic activities of Glyburide.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Glyburide.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Glyburide.
Rucaparib
The metabolism of Glyburide can be decreased when combined with Rucaparib.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Glyburide.
Saquinavir
The metabolism of Glyburide can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Glyburide can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Glyburide can be decreased when used in combination with Sarilumab.
Saxagliptin
Saxagliptin may increase the hypoglycemic activities of Glyburide.
Saxagliptin Anhydrous
Saxagliptin may increase the hypoglycemic activities of Glyburide.
Secobarbital
The metabolism of Glyburide can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the hypoglycemic activities of Glyburide.
Semaglutide
Semaglutide may increase the hypoglycemic activities of Glyburide.
Sertraline
The metabolism of Glyburide can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Glyburide can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Glyburide.
Siltuximab
The serum concentration of Glyburide can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Glyburide can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Glyburide.
Sirolimus
The therapeutic efficacy of Glyburide can be decreased when used in combination with Sirolimus.
Sitagliptin
Sitagliptin may increase the hypoglycemic activities of Glyburide.
Sitagliptin Phosphate
Sitagliptin may increase the hypoglycemic activities of Glyburide.
Sorafenib
The metabolism of Glyburide can be decreased when combined with Sorafenib.
Sotalol
Sotalol may increase the hypoglycemic activities of Glyburide.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Glyburide.
ST. JOHN'S WORT EXTRACT
The serum concentration of Glyburide can be decreased when it is combined with St. John's Wort.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Glyburide.
Sulfadiazine
The metabolism of Glyburide can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Glyburide can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Glyburide can be decreased when combined with Sulfisoxazole.
Sunitinib
Glyburide may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Glyburide can be decreased when used in combination with Tacrolimus.
Talinolol
Talinolol may increase the hypoglycemic activities of Glyburide.
Telaprevir
The metabolism of Glyburide can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Glyburide can be decreased when combined with Telithromycin.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Glyburide.
Temsirolimus
The therapeutic efficacy of Glyburide can be decreased when used in combination with Temsirolimus.
Terbutaline
Terbutaline may increase the hypoglycemic activities of Glyburide.
Terbutaline Sulfate
Terbutaline may increase the hypoglycemic activities of Glyburide.
Teriflunomide
The serum concentration of Glyburide can be increased when it is combined with Teriflunomide.
Tertatolol
Tertatolol may increase the hypoglycemic activities of Glyburide.
Testosterone
Testosterone may increase the hypoglycemic activities of Glyburide.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Glyburide.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Glyburide.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Glyburide.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Glyburide.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Glyburide.
Ticagrelor
The metabolism of Glyburide can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Glyburide can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypoglycemic activities of Glyburide.
Timolol Anhydrous
Timolol may increase the hypoglycemic activities of Glyburide.
Tipranavir
The therapeutic efficacy of Glyburide can be decreased when used in combination with Tipranavir.
Tocilizumab
The serum concentration of Glyburide can be decreased when it is combined with Tocilizumab.
Tolazamide
Tolazamide may increase the hypoglycemic activities of Glyburide.
Tolbutamide
The metabolism of Glyburide can be decreased when combined with Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Glyburide.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Glyburide.
Topiramate
The metabolism of Glyburide can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Glyburide.
Torsemide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Torasemide.
Tranylcypromine
The metabolism of Glyburide can be decreased when combined with Tranylcypromine.
Triamcinolone
The therapeutic efficacy of Glyburide can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Trichlormethiazide.
Trimethoprim
The metabolism of Glyburide can be decreased when combined with Trimethoprim.
Triptorelin
The therapeutic efficacy of Glyburide can be decreased when used in combination with Triptorelin.
Troglitazone
Troglitazone may increase the hypoglycemic activities of Glyburide.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Glyburide.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Glyburide.
Valproate
The metabolism of Glyburide can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Glyburide can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Glyburide can be decreased when combined with Valsartan.
Vemurafenib
The serum concentration of Glyburide can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Glyburide can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Glyburide can be decreased when combined with Verapamil.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Glyburide.
Vincristine
The excretion of Vincristine can be decreased when combined with Glyburide.
Voriconazole
The serum concentration of Glyburide can be increased when it is combined with Voriconazole.
Vorinostat
The therapeutic efficacy of Glyburide can be decreased when used in combination with Vorinostat.
Warfarin
Glyburide may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Glyburide can be decreased when combined with Zafirlukast.
Ziprasidone
The metabolism of Glyburide can be decreased when combined with Ziprasidone.
